Efficacy of Transdermal Oxybutynin in the Treatment of Overactive Bladder Syndrome: Does It Make Sense Using It in 2017?

OBJECTIVES: Evaluation of changes in symptoms among patients with overactive bladder syndrome treated with transdermal oxybutynin and tolerability after 12 months of follow-up. METHODS: This was a multicenter, retrospective, single-cohort, observational study. Changes in symptoms were evaluated prim...

Descripción completa

Detalles Bibliográficos
Autores principales: Vozmediano-Chicharro, Raúl, Madurga, Blanca, Blasco, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087608/
https://www.ncbi.nlm.nih.gov/pubmed/30151004
http://dx.doi.org/10.1155/2018/6782736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087608/
https://www.ncbi.nlm.nih.gov/pubmed/30151004
http://dx.doi.org/10.1155/2018/6782736

Ejemplares similares